about
Lymphoid neoplasia. Laser-capturing the essence of Hodgkin lymphoma.Revisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi-automated analysis reveals CD3 and FoxP3 as potential predictors of response to R-CHOPThe role of B7 family molecules in hematologic malignancyMyeloablative chemotherapy for chemo-sensitive recurrent follicular lymphoma: potential benefit in second relapseThe microenvironment of AIDS-related diffuse large B-cell lymphoma provides insight into the pathophysiology and indicates possible therapeutic strategiesSafe and efficacious use of recombinant human erythropoietin in malignancy.Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells.Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome.Bone marrow necrosis and fat embolism syndrome in sickle cell disease: increased susceptibility of patients with non-SS genotypes and a possible association with human parvovirus B19 infection.Psychosocial factors associated with impact of cancer in longterm haematological cancer survivors.Fertility and sexual function in long-term survivors of haematological malignancy: using patient-reported outcome measures to assess a neglected area of need in the late effects clinic.Posterior reversible encephalopathy syndrome following anti-lymphocyte globulin treatment for severe aplastic anaemia.Demonstration of durable graft versus lymphoma effects in Hodgkin's lymphoma.Early relapse and refractory disease remain risk factors in the anthracycline and autologous transplant era for patients with relapsed/refractory classical Hodgkin lymphoma: a single centre intention-to-treat analysisA shot in the arm for radiotherapyParenthood in long-term survivors after CHOP with or without etoposide treatment for aggressive lymphoma - response to Meissner et al
P50
Q34496358-FDC71EE0-73C8-4429-B3A1-481091BE9A42Q35146298-0C1A8A18-2BB6-43ED-BEC7-49979F8895B3Q36584814-A5CC4449-8AE7-424C-BAC4-B89D663B1BEBQ36862529-C0006A34-B3DA-4999-BFB3-6138390A4F8BQ37026769-74A488C5-1B07-43DE-B544-C120E63A30ECQ37056537-9F60DC66-676F-4477-A6BD-5336E355DC80Q37623812-DF76E816-F42A-47F5-94E7-848A64FFBB6EQ37659012-86BC1A93-D9CF-40A2-9EAB-F76222711620Q38182209-35A57607-574D-4A68-A566-96801884EFCBQ46315622-192847C1-7D7A-45F4-8149-464D4C739951Q48134526-7A4514E2-E2B6-4279-824D-F819A7279159Q48468736-38A79DF1-7380-4888-A2B1-012F93B884D0Q53246995-9FA16D29-DAE2-49B2-9BB0-66271884C019Q83189119-D2F17FA7-9C0B-4EB6-80A8-F6E025144701Q85889225-552DF591-C1F7-4EB4-AAEF-A722CC20FD06Q87578805-5904B84B-3F9F-4C6B-AF99-0B5980907D59
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Paul Greaves
@ast
Paul Greaves
@en
Paul Greaves
@es
Paul Greaves
@nl
type
label
Paul Greaves
@ast
Paul Greaves
@en
Paul Greaves
@es
Paul Greaves
@nl
prefLabel
Paul Greaves
@ast
Paul Greaves
@en
Paul Greaves
@es
Paul Greaves
@nl
P106
P31
P496
0000-0002-3318-7233